HCA Healthcare, Inc.
HCANYSECIK 860730HealthcareFiscal year ends Dec 31
Reports and events: 367 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2916:30 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001193125-26-437871 |
| 2026-10-2707:17 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-432665 |
| 2026-07-2916:10 ET | 8-K | 2.03 New direct financial obligation; 8.01 Other events | 0001193125-26-323731 |
| 2026-07-2816:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-321077 |
| 2026-07-2407:45 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-315151 |
| 2026-07-1407:40 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-302539 |
| 2026-06-1809:12 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-275086 |
| 2026-04-3016:10 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-197278 |
| 2026-04-2916:02 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-191444 |
| 2026-04-2816:20 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-187155 |
| 2026-04-2716:41 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-182265 |
| 2026-04-2407:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-174933 |
| 2026-03-1316:10 ET | DEF 14A | Proxy statementPeriod 2026-04-23 | 0001193125-26-106142 |
| 2026-02-2516:43 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-071880 |
| 2026-02-1019:47 ET | SCHEDULE 13D | Ownership report, active investor | 0001140361-26-004673 |
| 2026-02-1016:27 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-044769 |
| 2026-01-2707:12 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-023323 |
| 2025-10-3116:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-260809 |
| 2025-10-3016:30 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-258667 |
| 2025-10-2716:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-251612 |
| 2025-10-2407:16 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-249345 |
| 2025-08-0416:31 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-102056 |
| 2025-07-2507:46 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-098578 |
| 2025-07-1116:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-158208 |
| 2025-06-1016:10 ET | 8-K | 2.03 New direct financial obligation; 8.01 Other events | 0001193125-25-138463 |
| 2025-05-0116:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-061895 |
| 2025-04-2916:39 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-103953 |
| 2025-04-2507:48 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-058334 |
| 2025-03-1416:27 ET | DEF 14A | Proxy statementPeriod 2025-04-24 | 0001193125-25-054832 |
| 2025-02-2416:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-033430 |
| 2025-02-2116:10 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-031999 |
| 2025-02-2017:15 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-030833 |
| 2025-02-1808:44 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-028231 |
| 2025-02-1418:26 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-020134 |
| 2025-01-2407:40 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-008608 |
| 2024-10-3116:30 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-119581 |
| 2024-10-2507:38 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-117215 |
| 2024-08-1216:35 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-198927 |
| 2024-08-0816:57 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-197060 |
| 2024-07-2916:30 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-087322 |
| 2024-07-2308:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-182591 |
| 2024-05-0216:30 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-052195 |
| 2024-04-3016:27 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-24-125204 |
| 2024-04-2608:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-115857 |
| 2024-03-1516:24 ET | DEF 14A | Proxy statementPeriod 2024-04-25 | 0001193125-24-069180 |
| 2024-02-2616:35 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001193125-24-046248 |
| 2024-02-2616:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-046240 |
| 2024-02-2316:31 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-044555 |
| 2024-02-2108:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-040747 |
| 2024-02-1617:03 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-016524 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 18:36 ET. Listed shows no prices and gives no investment advice.